Published on in Vol 8, No 6 (2019): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/11553, first published .
Diet-Induced Alteration of Microbiota and Development of Obesity, Nonalcoholic Fatty Liver Disease, and Diabetes: Study Protocol of a Prospective Study

Diet-Induced Alteration of Microbiota and Development of Obesity, Nonalcoholic Fatty Liver Disease, and Diabetes: Study Protocol of a Prospective Study

Diet-Induced Alteration of Microbiota and Development of Obesity, Nonalcoholic Fatty Liver Disease, and Diabetes: Study Protocol of a Prospective Study

Journals

  1. Li G, Li W, Song B, Wang C, Shen Q, Li B, Tang D, Xu C, Geng H, Gao Y, Wang G, Wu H, Zhang Z, Xu X, Zhou P, Wei Z, He X, Cao Y. Differences in the Gut Microbiome of Women With and Without Hypoactive Sexual Desire Disorder: Case Control Study. Journal of Medical Internet Research 2021;23(2):e25342 View
  2. Huang W, Hua Y, Wang F, Xu J, Yuan L, Jing Z, Wang W, Zhao Y. Dietary betaine and/or TMAO affect hepatic lipid accumulation and glycometabolism of Megalobrama amblycephala exposed to a high-carbohydrate diet. Fish Physiology and Biochemistry 2024;50(1):59 View
  3. Han W, Huang C, Ji Y, Zhou L, Chen J, Hou J. Alterations in the Gut Microbiota and Hepatitis-B-Virus Infection in Southern Chinese Patients With Coexisting Non-Alcoholic Fatty Liver Disease and Type-2 Diabetes Mellitus. Frontiers in Medicine 2021;8 View
  4. Zhang D, Ma Y, Liu J, Wang D, Geng Z, Wen D, Chen H, Wang H, Li L, Zhu X, Wang X, Huang M, Zou C, Chen Y, Ma L. Fenofibrate improves hepatic steatosis, insulin resistance, and shapes the gut microbiome via TFEB-autophagy in NAFLD mice. European Journal of Pharmacology 2023;960:176159 View
  5. Cuatrecasas G, De Cabo F, Coves M, Patrascioiu I, Aguilar G, Cuatrecasas G, March S, Calbo M, Rossell O, Balfegó M, Benito C, Di Gregorio S, Garcia Lorda P, Muñoz E. Dapagliflozin added to metformin reduces perirenal fat layer in type 2 diabetic patients with obesity. Scientific Reports 2024;14(1) View
  6. Cuatrecasas G, Calbo M, Rossell O, Dachs L, Aguilar-Soler G, Coves M, Patrascioiu I, Benito C, March S, Balfegó M, Cuatrecasas G, Di Gregorio S, Marina I, Garcia-Lorda P, Munoz-Marron E, De Cabo F. Effect of Liraglutide in Different Abdominal Fat Layers Measured by Ultrasound: The Importance of Perirenal Fat Reduction. Obesity Facts 2024;17(4):347 View